ERK5-IN-6

CAS No. 2734916-64-2

ERK5-IN-6( —— )

Catalog No. M37089 CAS No. 2734916-64-2

ERK5-IN-6 is a potent inhibitor of ERK5 kinase.ERK5-IN-6 exhibits antiproliferative activity, anticonvulsant activity, and antitumor activity, and can be used in the study of central nervous system-related disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 In Stock
5MG 459 In Stock
10MG 657 In Stock
25MG 994 In Stock
50MG 1371 In Stock
100MG 1773 In Stock
500MG 3537 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ERK5-IN-6
  • Note
    Research use only, not for human use.
  • Brief Description
    ERK5-IN-6 is a potent inhibitor of ERK5 kinase.ERK5-IN-6 exhibits antiproliferative activity, anticonvulsant activity, and antitumor activity, and can be used in the study of central nervous system-related disorders.
  • Description
    ERK5-IN-6 (compound 5J)is an ERK5 kinase inhibitor with anticancer activity. ERK5-IN-6 exhibits good anti-proliferative activity with the IC50 value of 4.56 μg/mL for A549 cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    ERK
  • Recptor
    ERK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2734916-64-2
  • Formula Weight
    339.43
  • Molecular Formula
    C23H21N3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N1=CC=CC2=C1NC=C2C3=CCN(CC=4C=CC=5C=CC=CC5C4)CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Qin Zhang, et al. Design, synthesis and SAR of novel 7-azaindole derivatives as potential Erk5 kinase inhibitor with anticancer activity. Bioorg Med Chem. 2023 Oct 14:95:117503. ?
molnova catalog
related products
  • DEL-22379

    A small molecule inhibitor of ERK dimerization with IC50 of 0.5 uM, without affecting ERK phosphorylation.

  • ERK-IN-3

    ERK-IN-3 is a potent and orally active inhibitor of ERK. It inhibits ERK1/2 with low single-digit nM IC50 values. It can be used for the research of cancers driven by RAS mutations.

  • MK-8353

    MK-8353 (SCH-900353) is a?highly potent, orally bioavailable, dual-specificity ERK1/2 inhibitor with IC50 of 23.0/8.8 nM, respectively.